Journal of IiME Volume 3 Issue 1 www.investinme.org Human enteroviruses and chronic infectious disease (continued) Chapman. 2005. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. J Virol 79:7024-41. 20. Knip, M., and H. K. Akerblom. 1999. Environmental factors in the pathogenesis of type 1 diabetes mellitus. Exp Clin Endocrinol Diabetes 107 Suppl 3:S93-S100. 21. Martino, T. A., P. Liu, M. Petric, and M. J. Sole. 1995. Enteroviral myocarditis and dilated cardiomyopathy: a review of clinical and experimental studies., p. 291352. In R. HA (ed.), Human Enterovirus Infections. ASM Press, Washington DC. 22. Minor, P. D. 2003. Polio vaccines and the cessation of vaccination. Exp Rev Vaccines 2:99-104. 23. Mucklebaur, J. K., and M. G. Rossmann. 1997. The structure of coxsackievirus B3. Curr Top Microbiol Immunol 223:191-208. 24. Oberste, M. S., K. Maher, M. R. Flemister, G. Marchetti, D. R. Kilpatrick, and M. A. Pallansch. 2000. Comparison of classic and molecular approaches for the identification of untypeable enteroviruses. J Clin Microbiol 38:1170-1174. 25. Oberste, M. S., K. Maher, D. Kilpatrick, M. Flimister, B. Brown, and M. A. Pallansch. 1999. Typing of human enteroviruses by partial sequencing of VP1. J Clin Microbiol 37:1288-1293. 26. Oberste, M. S., K. Maher, A. J. Williams, N. Dybdahl-Sissoko, B. A. Brown, M. S. Gookin, S. Penaranda, N. Mishrik, M. Uddin, and M. A. Pallansch. 2006. Species-specific RT-PCR amplification of human enteroviruses: a tool for rapid species identification of uncharacterized enteroviruses. J Gen Virol 87:119-28. 27. Pallansch, M. A., and R. Roos. 2007. Enteroviruses: Polioviruses, coxsackieviruses, echoviruses and newer enteroviruses, p. 839-893. In D. M. Knipe (ed.), Fields Virology, vol. 1. Wolters Kluwer, Philadelphia. 28. Romero, J. T. 2008. Pediatric group B coxsackievirus infections. Curr Topics Microbiol Immunol 323:223-239. 29. Shanes, J., J. Ghali, M. Billingham, V. Ferrans, J. Fenoglio, W. Edwards, C. Tsai, J. Invest in ME (Charity Nr. 1114035) Page 31/76 Saffitz, J. Isner, S. Furner, and e. al. 1987. Interobserver variability in the pathologic interpretation of endomyocardial biopsy results. Circulation 75:401-405. 30. Tracy, S., and K. M. Drescher. 2007. Coxsackievirus infections and NOD mice: Relevant models of protection from, and induction of, type 1 diabetes. Ann N Y Acad Sci. 31. Tracy, S., M. S. Oberste, and K. M. Drescher. 2008. Group B Coxsackieviruses. Curr Topics Microbiol Immunol 323. 32. Van Creveld, S., and H. De Jager. 1956. Myocarditis in newborns, caused by coxsackie virus. Ann Pediat 187:100-112. 33. Wessely, R., K. Klingel, L. F. Santana, N. Dalton, M. Hongo, W. Jonathan Lederer, R. Kandolf, and K. U. Knowlton. 1998. Transgenic expression of replicationrestricted enteroviral genomes in heart muscle induces defective excitationcontraction coupling and dilated cardiomyopathy. J Clin Invest 102:1444-53. The Enterovirus Foundation was founded in November 2008 and is a non-profit organisation created to fund research to discover the persistent effects of enteroviruses, to determine the role they play in both acute and chronic disease, and to develop treatments to cure and prevent these diseases. More details at - www.enterovirusfoundation.org
32 Publizr Home